Your browser doesn't support javascript.
loading
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
Romito, Ilaria; Porru, Manuela; Braghini, Maria Rita; Pompili, Luca; Panera, Nadia; Crudele, Annalisa; Gnani, Daniela; De Stefanis, Cristiano; Scarsella, Marco; Pomella, Silvia; Mortera, Stefano Levi; de Billy, Emmanuel; Conti, Adrian Libenzio; Marzano, Valeria; Putignani, Lorenza; Vinciguerra, Manlio; Balsano, Clara; Pastore, Anna; Rota, Rossella; Tartaglia, Marco; Leonetti, Carlo; Alisi, Anna.
Afiliação
  • Romito I; Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children's Hospital, IRCCS, Via S. Paolo, 15, 00146, Rome, Italy.
  • Porru M; Unit of Oncogenomic and Epigenetic, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Braghini MR; Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children's Hospital, IRCCS, Via S. Paolo, 15, 00146, Rome, Italy.
  • Pompili L; Unit of Oncogenomic and Epigenetic, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Panera N; Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children's Hospital, IRCCS, Via S. Paolo, 15, 00146, Rome, Italy.
  • Crudele A; Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children's Hospital, IRCCS, Via S. Paolo, 15, 00146, Rome, Italy.
  • Gnani D; Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
  • De Stefanis C; Core Facilities, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Scarsella M; Core Facilities, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Pomella S; Department of Paediatric Haematology/Oncology and Cellular and Gene Therapy, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Mortera SL; Unit of Human Microbiome, Multimodal Laboratory Medicine Research Area, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • de Billy E; Department of Paediatric Haematology/Oncology and Cellular and Gene Therapy, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Conti AL; Core Facilities, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Marzano V; Unit of Human Microbiome, Multimodal Laboratory Medicine Research Area, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Putignani L; Unit of Human Microbiome, Multimodal Laboratory Medicine Research Area, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Vinciguerra M; Unit of Microbiomics, Microbiology and Immunological Diagnostics, Department of Diagnostics and Laboratory Medicine Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Balsano C; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
  • Pastore A; Department of Translational Stem Cell Biology, Research Institute of the Medical University of Varna, 9002, Varna, Bulgaria.
  • Rota R; Department of Life, Health and Environmental Sciences MESVA, University of L'Aquila, L'Aquila, Italy.
  • Tartaglia M; Francesco Balsano Foundation, Rome, Italy.
  • Leonetti C; Research Unit of Diagnostical and Management Innovations, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Alisi A; Department of Paediatric Haematology/Oncology and Cellular and Gene Therapy, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
J Exp Clin Cancer Res ; 41(1): 40, 2022 Jan 27.
Article em En | MEDLINE | ID: mdl-35086550
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article